ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted November 21, 2013

Weight Loss Supplement Recalled

On November 14, 2013, Deseo Rebajar Inc. issued a recall of one lot of weight loss supplement Adipotrim XT because it was found to contain undeclared fluoxetine.

Fluoxetine is an FDA approved selective serotonin reuptake inhibitor (SSRI) drug prescribed to treat depression, anxiety, and other conditions. SSRI drugs are associated with serious side effects including suicidal thinking, abnormal bleeding, and seizures, and can interact with other common medications such as aspirin and ibuprofen, which can cause ventricular arrhythmia or sudden death.

Recalled Adipotrim XT was sold directly to customers in Deseo Rebajar offices in Fajardo, Caguas and Bayamon, Puerto Rico, and on the company's website www.deseorebajar.com. It is packaged in 30-count plastic bottles labeled with lot number #052012.

(See ConsumerLab.com's Reviews of Weight Loss Supplements and Sexual Enhancement Supplements for tests of related products.)

Consumers who have purchased this supplement should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.

See Related Warnings:

FDA Warns of Five More Weight Loss Supplements Containing Undeclared Drugs

Weight Loss Supplement Found to Contain Drugs

FDA Warns Consumers Of Weight Loss Supplement Containing Undeclared Drug

Weight Loss Supplement Recalled Due To Undeclared Drug

FDA Seizes Weight Loss Supplements Containing Undeclared Drug

Rx Drugs Found in Weight Loss and Enhancement Supplements

Recall of "Slimming" Supplements Spiked with Drug

For more about this recall, use the link below.